Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $TZYM Ocera Therapeutics, Inc.
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Brothers Life Sciences Capital (GP), LLC in Ocera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 3,540,015 shares
Latest Transaction: Mar 14 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in Ocera Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, BCRX, GHDX, HRTX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 3.01 | 34,544 | 103,822 | 3,540,015 | 3.5 M to 3.5 M (+0.99 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.99 | 56,294 | 168,268 | 3,505,471 | 3.4 M to 3.5 M (+1.63 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.96 | 159,015 | 470,382 | 3,449,177 | 3.3 M to 3.4 M (+4.83 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.55 | 572,737 | 1,460,479 | 3,290,162 | 2.7 M to 3.3 M (+21.08 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.34 | 327,769 | 766,848 | 2,717,425 | 2.4 M to 2.7 M (+13.72 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.87 | 44,467 | 83,153 | 2,389,656 | 2.3 M to 2.4 M (+1.90 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.89 | 16,326 | 30,788 | 2,345,189 | 2.3 M to 2.3 M (+0.70 %) |
Page: 1